BeOne Medicines (BEIGF) EBT (2015 - 2026)
BeOne Medicines (BEIGF) reported EBT of $259.2 million for Q1 2026, up 1140.26% year-over-year from $20.9 million in Q1 2025, and up 73.69% quarter-over-quarter from $149.2 million in Q4 2025.
BeOne Medicines (BEIGF) EBT (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of EBT data on file, last reported at $259.2 million in Q1 2026.
- EBT for Q1 2026 came in at $259.2 million, up 1140.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $655.2 million (up 343.85% YoY), and the FY2025 annual result was $416.9 million, up 178.21% from the prior year.
- EBT advanced to $259.2 million in Q1 2026 per BEIGF's latest filing, from $149.2 million in the prior quarter.
- Over five years, EBT peaked at $259.2 million in Q1 2026 and troughed at -$557.6 million in Q2 2022.
- A 5-year average of -$155.5 million and a median of -$105.9 million in 2024 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2026: EBT slumped 780.92% in 2022, then surged 1140.26% in 2026.
- A 5-year view of EBT shows it stood at -$431.0 million in 2022, then gained by 18.61% to -$350.8 million in 2023, then soared by 75.67% to -$85.4 million in 2024, then jumped by 274.86% to $149.2 million in 2025, then soared by 73.69% to $259.2 million in 2026.
- Business Quant data shows BEIGF's EBT at $259.2 million in Q1 2026, $149.2 million in Q4 2025, and $147.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -56.48 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 259.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259.22 Mn |
| Dec 31, 2025 | 149.24 Mn |
| Sep 30, 2025 | 147.16 Mn |
| Jun 30, 2025 | 99.55 Mn |
| Mar 31, 2025 | 20.90 Mn |
| Dec 31, 2024 | -85.35 Mn |
| Sep 30, 2024 | -98.30 Mn |
| Jun 30, 2024 | -105.92 Mn |
| Mar 31, 2024 | -243.43 Mn |
| Dec 31, 2023 | -350.77 Mn |
| Sep 30, 2023 | 229.34 Mn |
| Jun 30, 2023 | -367.46 Mn |
| Mar 31, 2023 | -336.94 Mn |
| Dec 31, 2022 | -430.97 Mn |
| Sep 30, 2022 | -551.24 Mn |
| Jun 30, 2022 | -557.59 Mn |
| Mar 31, 2022 | -421.25 Mn |
| Dec 31, 2021 | -606.03 Mn |
| Sep 30, 2021 | -433.08 Mn |
| Jun 30, 2021 | -480.57 Mn |